Results of Aelis Farma Combined General Meeting of May 24, 2023

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces that all the resolutions recommended by the Board of directors were adopted by the Combined General Meeting of shareholders. Aelis Farma held its combined general ... Read More

Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) ... Read More

seven9 Reimagines Social Cannabis Traditions for Modern Consumers With OOKA’s Luxury-Lifestyle Inhalation Ecosystem

LOS ANGELES–(BUSINESS WIRE)–OOKA, a lifestyle and technology-forward inhalation-device company, today officially introduces a first-of-its-kind consumption ecosystem, the OOKA Sense Station. seven9’s premium cannabis pods, compatible for use with this revolutionary device, marks the first of many efforts between the synergistic brands, focused on modernizing social consumption traditions through cleaner, smoother ... Read More